跳转至内容
Merck
CN
  • Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement.

Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement.

Journal of inherited metabolic disease (2000-02-22)
G Touati, E Rusthoven, E Depondt, C Dorche, M Duran, B Heron, D Rabier, M Russo, J M Saudubray
摘要

We report an attempt at dietetic therapy in two unrelated patients with isolated sulphite oxidase deficiency, with a mild clinical course and late onset of symptoms. In case 1, disease started at 15 months with an acute crisis of agitation, unexplained crying and restlessness following otitis. Case 2 was diagnosed at 10 months when she presented with slight motor delay and dislocation of lenses. In both cases, sulphite oxidase activity measured in fibroblasts was undetectable. Therapy consisted of a diet low in protein from natural foods (daily methionine intake 130-150 mg) and a synthetic amino acid mixture (50 g per day) without cystine and methionine (Xmet, Cys Maxamaid, SHS International Ltd). A comparison of clinical and biochemical parameters was made between the period before treatment and after 2 years of treatment. Restriction in protein and sulphur amino acids brought about a dramatic decrease of urinary thiosulphate and S-sulphocysteine. It also brought about a generalized hypoaminoacidaemia with a low plasma methionine and cystine in both patients. Furthermore, both patients grew normally with no signs of neurological deterioration, and there was evidence of progress in psychomotor development.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
牛磺酸, ≥99%
Sigma-Aldrich
牛磺酸, suitable for cell culture, meets USP testing specifications
Sigma-Aldrich
牛磺酸, BioUltra, ≥99.5% (T)
Supelco
牛磺酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-半胱氨酸S-硫酸盐, ≥98% (TLC)
Sigma-Aldrich
牛磺酸, ≥98%, FG
SAFC
牛磺酸